Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis

被引：115
|
作者：
Qureshi, AI
Choudhry, MA
Akbar, MS
Mohammad, Y
Chua, HC
Yahia, AM
Ulatowski, JA
Krendel, DA
Leshner, RT
机构：
[1] Johns Hopkins Hosp, Dept Neurol, Baltimore, MD USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurol, Richmond, VA 23298 USA
[3] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA USA
[4] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA
来源：
NEUROLOGY | 1999年 / 52卷 / 03期
关键词：
D O I：
10.1212/WNL.52.3.629
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We performed a retrospective multicenter chart review to compare the efficacy and tolerance of plasma exchange (PE) and intravenous immunoglobulin (IVIg) in treatment of 54 episodes of myasthenic crisis. After adjustment for other variables, PE (compared with Mg) was associated with a superior ventilatory status at 2 weeks (partial F = 6.2, p = 0.02) and 1 month functional outcome (partial F = 4.5, p = 0.04). However, the complication rate was higher with PE compared with IVIg (13 versus 5 episodes, p = 0.07).
引用
收藏
页码：629 / 632
页数：4
相关论文
共 50 条
  • [31] Improvement of quality of life after therapeutic plasma exchange in patients with myasthenic crisis
    Rozmilowska, Izabela
    Adamczyk-Sowa, Monika
    Rutkowska, Katarzyna
    Pierzchala, Krystyna
    Misiolek, Hanna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2016, 50 (06) : 418 - 424
  • [32] Intravenous immunoglobulin for preparing myasthenia gravis patients for thymectomy and other surgical procedures preventing myasthenic crisis
    Gamez, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 178 : 134 - 135
  • [33] Treatment of Neonatal Hemochromatosis with Exchange Transfusion and Intravenous Immunoglobulin
    Rand, Elizabeth B.
    Karpen, Saul J.
    Kelly, Susan
    Mack, Cara L.
    Malatack, J. Jeffrey
    Sokol, Ronald J.
    Whitington, Peter F.
    JOURNAL OF PEDIATRICS, 2009, 155 (04): : 566 - 571
  • [34] Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
    B Charra
    A Hachimi
    A Benslama
    S Motaouakkil
    Critical Care, 13 (Suppl 1):
  • [35] Neonatal Hemochromatosis: Treatment with Exchange Transfusion and Intravenous Immunoglobulin
    Ehab Mohamed Hantash
    Abdulrahman Al Zahrani
    Mohamed Abdoun
    Syeda Naqvi
    Georges E. Nawfal
    Dr. Sulaiman Al Habib Medical Journal, 2021, 3 (3): : 99 - 103
  • [36] Safety of intravenous immunoglobulin and plasma exchange in critically ill patients
    Clark, Sarah L.
    Rabinstein, Alejandro A.
    NEUROLOGICAL RESEARCH, 2015, 37 (07) : 593 - 598
  • [37] Management of catastrophic antiphospholipid syndrome: Plasma exchange or intravenous immunoglobulin?
    Erkan, D
    Asherson, R
    Cervera, R
    Peterson, M
    Font, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 326 - 326
  • [38] Risk of Thrombotic Events after Exposure to Intravenous Immunoglobulin or Plasma Exchange for Treatment of Neurologic Disease
    Jin, Peter H.
    Stein, Laura K.
    Shin, Susan C.
    Dhamoon, Mandip S.
    NEUROLOGY, 2019, 92 (15)
  • [39] Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura: A case report
    Moore, J. C.
    Arnold, D. M.
    Leber, B. F.
    Clare, R.
    Molnar, G. J.
    Kelton, J. G.
    TRANSFUSION, 2006, 46 (09) : 44A - 45A
  • [40] Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis with Plasma Exchange, Rituximab, and Intravenous Immunoglobulin, and Steroids
    Khangoora, V.
    Patel, M. P.
    Sill, J. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345